{
  "id": 10383866,
  "title": "Hyloris Partner AFT Signs Exclusive Japan Deal For Maxigesic IV",
  "url": "https://urgent.news/2026/09/28/hyloris-partner-aft-signs-exclusive-japan-deal-for-maxigesic-iv",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T05:29:46.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/hyloris-partner-aft-signs-exclusive-japan-deal-maxigesic-iv"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Hyloris Pharmaceuticals SA (HYL.BR) announced that its partner AFT Pharmaceuticals Ltd. (AFT.NZ) has entered into an exclusive agreement with Mikasa Seiyaku Co Ltd. for the commercialization of Maxigesic IV in Japan.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}